BREM FOUNDATION TO DEFEAT BREAST CANCER (EIN 202756827) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2006

Legal Domicile

Principal Officer

Clare Dougherty

Phone

2025051104

Tax Period

2023-01-01 to 2023-12-31

BREM FOUNDATION TO DEFEAT BREAST CANCER, founded in 2006, is a community nonprofit in the Medical Research sector that reported $1.2M in total revenue in fiscal year 2023. Revenue grew 17% year-over-year, indicating healthy expansion.

Mission

Brem Foundation to Defeat Breast Cancer champions early detection of breast cancer to improve health outcomes for all through innovation, education, equitable access, and targeted advocacy.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2023)

Revenue Breakdown

Contributions & Grants $1,212,674

Program Service Revenue $0

Investment Income $14,165

Other Revenue $-75,557

TOTAL REVENUE $1,151,282

Expense Breakdown

Grants Paid $160,000

Salaries & Benefits $646,146

Fundraising Expenses $263,649

Program Expenses $727,072

Other Expenses $382,757

TOTAL EXPENSES $1,188,903

Year-over-Year Comparison

	2023	2022	Change
Revenue	$1,151,282	$984,637	+0.2%
Expenses	$1,188,903	$1,006,662	+0.2%
Net Income	$-37,621	$-22,025	+0.7%

Key Indicators

✓ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

Volunteers

Governance Policies

✗ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

$263,063

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
Clare Dougherty	CEO	40.00	Officer	$230,960	$32,103	$263,063
Cheryl Skillin	Secretary	5.00	Officer Director	$0	$0	$0
Mike Butchko	Director	1.00	Director	$0	$0	$0
Rachel Brem	Director	1.00	Director	$0	$0	$0
Gina Kim-Ahn	Director	1.00	Director	$0	$0	$0
Jamie Gorksi	Director	1.00	Director	$0	$0	$0
Kathy Ingber	Director	1.00	Director	$0	$0	$0
Melanie Marcus	Director	1.00	Director	$0	$0	$0
Alexis Solis	Director	1.00	Director	$0	$0	$0
Rachel Jones	Director	1.00	Director	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2024	No data	No data	No data	No data
2023	$1,151,282	$1,188,903	$641,371	$-37,621
2022	$984,637	$1,006,662	$655,636	$-22,025
2021	$846,932	$834,082	$741,999	$12,850
2020	$701,574	$679,392	$738,295	$22,182

BREM FOUNDATION TO DEFEAT BREAST CANCER